1. Home
  2. |Insights
  3. |CPhI Biosimilars India 2009

CPhI Biosimilars India 2009

Event | 12.01.09 - 12.02.09, 12:00 AM UTC - 12:00 AM UTC

CPhI Biosimilars India 2009 consists of 3 half-day conference modules, each designed to provide solutions to the strategic issues facing the Indian biosimilars market. Based on in-depth research, each module provides three and a half hours of business-critical information delivered by a hand-selected panel of expert speakers.

Keith Harrison and Teresa Rea are speakers at this conference. Mr. Harrison has a session on "Mapping out the latest developments in European and US biosimilar regulation - achieving cost effective compliance." Ms. Rea is addressing "Exploring patent concerns and effects on Biosimilars."

Participants

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures. 

View All Insights